Xconomy | Kendall Square - 
					Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
Biogen Idec, Elan Start First Cancer Trial With Tysabri Luke Timmerman 09/05/08 Boston
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries Luke Timmerman 09/05/08 Seattle
Alnylam Sees Opportunity in Turning Genes On, And Off Luke Timmerman 09/05/08 Boston
Gates Foundation Calls for Proposals to Solve Global Health “Grand Challenges” Luke Timmerman 09/04/08 Seattle
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease Luke Timmerman 09/04/08 Seattle
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA Luke Timmerman 09/03/08 Seattle
Oncothyreon To Sell Stock, Bet Resources on Developing Two Cancer Drugs Luke Timmerman 09/02/08 Seattle
Targanta Antibiotic Shown Effective in Less-Frequent Dose Luke Timmerman 09/02/08 Boston
Hepregen Raises $3 Million To Screen Drugs for Liver Damage Luke Timmerman 09/02/08 Boston
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval Luke Timmerman 09/02/08 Seattle
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration Luke Timmerman 09/02/08 Boston
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News Rebecca Zacks 09/02/08 Boston
Ikaria Developing Drug For “Hibernation-on-Demand,” Could Pull Off Biggest Biotech IPO Ever, VC Says Luke Timmerman 09/02/08 Seattle
Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company Luke Timmerman 09/02/08 Boston
Boston Scientific Gets Damages Reduced in Patent Case with Medtronic Luke Timmerman 08/29/08 Boston
ZymoGenetics Sells Land for $11.5 Million Luke Timmerman 08/29/08 Seattle
Impel NeuroPharma Develops Novel Delivery System to Get Drugs Into the Brain Luke Timmerman 08/29/08 Seattle
Quanterix Developing Instrument to Detect Cancer at its Earliest, Most Curable Stages Luke Timmerman 08/29/08 Boston
SonoSite Marketing Boss Resigns to Take Job at Smith & Nephew Luke Timmerman 08/28/08 Seattle
Dendreon Rival Suffers Meltdown, Investors Sitting Tight For Next Big Clinical Trial News Luke Timmerman 08/28/08 Seattle
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections Luke Timmerman 08/28/08 Seattle
Ultrasound Stethoscopes, Stealthy Software, A New Enzyme Startup, and More from Alexandria Real Estate’s Summer Celebration Gregory T. Huang 08/28/08 Seattle
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis Luke Timmerman 08/27/08 Boston
UW TechTransfer’s Linden Rhoads Aiming to Nurture More Startups, Entice More VCs to Look at UW’s Research Cupboard Luke Timmerman 08/27/08 Seattle
Amazon Acquires Shelfari; SnapIn Gets Snapped Up by Nuance; AltaRock Closes Funding Round with Vulcan, Google, and ATV; & More Gregory T. Huang 08/27/08 Seattle
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News Rebecca Zacks 08/27/08 Boston
QLT Licenses Atrigel Rights to Reckitt Benckiser Luke Timmerman 08/26/08 Seattle
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling Luke Timmerman 08/26/08 Boston
Polaris and MIT’s Langer Meet L’Oreal. Don’t Believe It? There’s “Living Proof” Ryan McBride 08/26/08 Boston
With Intellectual Ventures, Nathan Myhrvold Out to Create “Invention Capital” Industry—and Stop Hurricanes, Malaria, and Global Warming in the Process (Part 2) Gregory T. Huang 08/26/08 Seattle
Page 1 of 18 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.